Biotech News

Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement

BMYBristol-Myers Squibb Company (BMY)BMYBristol-Myers Squibb CompanyCompany update

Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement

October 01, 2026

Second-Year Champions in Care Campaign Introduces $1 Million Community Grant Program for Medically Underserved Communities

Bristol Myers Squibb (NYSE: BMY) today announced the expansion of Champions in Care , the company's initiative honoring healthcare professionals (HCPs), first launched in 2025. Now in its second year, the campaign builds on its inaugural effort that celebrated HCPs across therapeutic areas through digital, social and live engagement. This year's expansion introduces new opportunities for HCPs to extend their impact beyond patient care and into the communities they serve.

As part of this year's campaign, Bristol Myers Squibb will award $1 million in grants to nonprofit organizations supporting medically underserved communities across the United States. Grant applicants will be identified through an anonymous nomination process designed to recognize organizations helping to close gaps in care. We welcome nominations from HCPs, who we know are uniquely positioned to understand their communities’ most pressing needs and the barriers patients face in accessing care.

"Last year, we launched Champions in Care to recognize the extraordinary impact HCPs have on patients, families and communities," said Adam Lenkowsky , executive vice president, chief commercialization officer, Bristol Myers Squibb. "This year, we're building on that foundation by giving HCPs the opportunity to acknowledge organizations that support the medically underserved communities they serve."

More information about the nomination process and criteria can be found here . The deadline for nominations is November 30, 2026. Nomination does not guarantee funding; nominated organizations may be invited to apply for a grant and will be considered through a separate review and selection process before any awards are made.

Throughout the remainder of the year, Bristol Myers Squibb will bring Champions in Care to life through additional social, digital and live medical meeting activations that celebrate HCPs and highlight their contributions to patients and communities around the world.

For more information about Champions in Care and how Bristol Myers Squibb is recognizing the HCPs that care for all of us, visit www.ChampionsInCare.com .

About Bristol Myers Squibb: Transforming Patients’ Lives Through Science At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com or follow us on LinkedIn , X , YouTube , Facebook and Instagram .

corporatefinancial-news

Source: Bristol Myers Squibb

Media downloads:

Categories: Press Releases

Related news

BMYBMYBristol-Myers Squibb Company2026-10-08 10:59 EST

Bristol Myers Squibb Announces ZENBEXUS (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior Progression-Free Survival vs. Standard of Care in Relapsed and Refractory Multiple Myeloma in Phase 3...

BMYBMYBristol-Myers Squibb Company2026-11-06 21:00 EST

Bristol Myers Squibb Presents 56-Week Phase 3 Data in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) for Camzyos (mavacamten) at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions

BNTXBioNTech2026-10-25 07:30 EST

BioNTech und Bristol Myers Squibb präsentieren ermutigende Daten aus globaler Phase-2-Studie mit Pumitamig bei fortgeschrittenem nicht-kleinzelligem Lungenkrebs nach Progression der Erkrankung unter einer Immuntherapie und Chemotherapie

GPCRStructure Therapeutics2026-11-04 12:30 EST

Structure Therapeutics to Participate in the Jefferies Global Healthcare Conference

GERNGeron2026-11-03 13:00 EST

Geron Corporation to Participate in the Stifel 2026 Healthcare Conference

COGTCogent Biosciences2026-10-27 20:01 EST

Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference

REGNRegeneron Pharmaceuticals2026-10-26 11:00 EST

Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparedness

GSKGSK plc2026-10-06 14:00 EST

ViiV Healthcare’s long-acting HIV treatment Cabenuva (cabotegravir + rilpivirine) meets primary endpoint of superior viral suppression vs. daily oral therapy in people with viremia

REGNRegeneron Pharmaceuticals2026-10-06 11:00 EST

Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026

BMYBristol-Myers Squibb Company

Diversified Global Biopharma Bristol Myers Squibb is a global biopharmaceutical company with commercial and development franchises spanning oncology, hematology, cardiovascular disease, immunology and neuroscience. Its growth portfolio combines established medicines, newer launches and late-stage candidates intended to offset the erosion...

Recent company news

Stock data

Close
63.13 USD
Market cap
111.21B USD
Exchange
NYSE
Sector
Oncology, Immunotherapy
Location
Princeton, New Jersey